118 related articles for article (PubMed ID: 35656757)
1. Clinical efficacy of Fluorometholone versus Loteprednol eye drops after photorefractive keratectomy: A triple-blinded randomized controlled trial.
Razmjoo H; Mikaniki M; Peyman A; Mikaniki E; Abounoori M; Pourazizi M
Eur J Ophthalmol; 2023 Jan; 33(1):595-601. PubMed ID: 35656757
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper.
Mifflin MD; Betts BS; Frederick PA; Feuerman JM; Fenzl CR; Moshirfar M; Zaugg B
Clin Ophthalmol; 2017; 11():1113-1118. PubMed ID: 28652697
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Loteprednol with Fluorometholone after Myopic Photorefractive Keratectomy.
Karimian F; Faramarzi A; Fekri S; Mohammad-Rabie H; Najdi D; Doozandeh A; Delfaza-Baher S; Yaseri M
J Ophthalmic Vis Res; 2017; 12(1):11-16. PubMed ID: 28299001
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of loteprednol etabonate versus fluorometholone in the treatment of patients after corneal refractive surgery: a meta-analysis.
Zhang X; Shen Z; Sun H; Bu F; Huang T
Int Ophthalmol; 2023 Jul; 43(7):2477-2486. PubMed ID: 36869982
[TBL] [Abstract][Full Text] [Related]
5. Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery.
Shokoohi-Rad S; Daneshvar R; Jafarian-Shahri M; Rajaee P
J Curr Ophthalmol; 2018 Jun; 30(2):130-135. PubMed ID: 29988925
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial comparing dexamethasone with loteprednol etabonate on postoperative photorefractive keratectomy.
Thanathanee O; Sriphon P; Anutarapongpan O; Athikulwongse R; Thongphiew P; Rangsin R; Suwan-apichon O
J Ocul Pharmacol Ther; 2015 Apr; 31(3):165-8. PubMed ID: 25555173
[TBL] [Abstract][Full Text] [Related]
7. A randomized, comparative study of fluorometholone 0.2% and fluorometholone 0.1% acetate after photorefractive keratectomy.
Vetrugno M; Quaranta GM; Maino A; Cardia L
Eur J Ophthalmol; 2000; 10(1):39-45. PubMed ID: 10744204
[TBL] [Abstract][Full Text] [Related]
8. Effect of Short Versus Long-Term Steroid on Corneal Haze After Photorefractive Keratectomy: A Randomized, Double-Masked Clinical Trial.
Hashemi H; Pakbin M; Pakravan M; Fotouhi A; Jafarzadehpur E; Aghamirsalim M; Khabazkhoob M
Am J Ophthalmol; 2022 Mar; 235():211-220. PubMed ID: 34624248
[TBL] [Abstract][Full Text] [Related]
9. Use of loteprednol for routine prophylaxis after photorefractive keratectomy.
Mifflin MD; Leishman LL; Christiansen SM; Sikder S; Hsu M; Moshirfar M
Clin Ophthalmol; 2012; 6():653-9. PubMed ID: 22570546
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical corticosteroids after photorefractive keratectomy.
Chatterjee A; Shah S; Galway G
J Refract Surg; 1997 Aug; 13(5 Suppl):S454-5. PubMed ID: 9286795
[TBL] [Abstract][Full Text] [Related]
11. Correlation of subepithelial haze and refractive regression 1 month after photorefractive keratectomy for myopia.
Siganos DS; Katsanevaki VJ; Pallikaris IG
J Refract Surg; 1999; 15(3):338-42. PubMed ID: 10367577
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of flurbiprofen and diclofenac on refractive outcome and corneal haze after photorefractive keratectomy.
Baek SH; Choi SY; Chang JH; Wee WR; Lee JH
J Cataract Refract Surg; 1997 Nov; 23(9):1317-23. PubMed ID: 9423902
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
Sheppard JD; Comstock TL; Cavet ME
Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Loteprednol 0.5% and Fluorometholone 0.1% After Strabismus Surgery in Children.
Yoo YJ; Yang HK; Hwang JM
J Ocul Pharmacol Ther; 2018; 34(6):468-476. PubMed ID: 29958057
[TBL] [Abstract][Full Text] [Related]
15. Results of phase III excimer laser photorefractive keratectomy for myopia. The Summit PRK Study Group.
Hersh PS; Stulting RD; Steinert RF; Waring GO; Thompson KP; O'Connell M; Doney K; Schein OD
Ophthalmology; 1997 Oct; 104(10):1535-53. PubMed ID: 9331190
[TBL] [Abstract][Full Text] [Related]
16. Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation.
Howes JF; Baru H; Vered M; Neumann R
J Ocul Pharmacol; 1994; 10(1):289-93. PubMed ID: 8207332
[TBL] [Abstract][Full Text] [Related]
17. Fluorometholone-induced cataract after photorefractive keratectomy.
Bilgihan K; Gürelik G; Akata F; Hasanreisoglu B
Ophthalmologica; 1997; 211(6):394-6. PubMed ID: 9380362
[TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery.
Salinger CL; Gordon M; Jackson MA; Perl T; Donnenfeld E
Clin Ophthalmol; 2015; 9():2089-97. PubMed ID: 26609219
[TBL] [Abstract][Full Text] [Related]
19. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.
Hersh PS; Brint SF; Maloney RK; Durrie DS; Gordon M; Michelson MA; Thompson VM; Berkeley RB; Schein OD; Steinert RF
Ophthalmology; 1998 Aug; 105(8):1512-22, discussion 1522-3. PubMed ID: 9709767
[TBL] [Abstract][Full Text] [Related]
20. [Medicamental correction of pathomorphological changes of the ocular surface in patients with steroid therapy intolerance after photorefractive keratectomy].
Eskina EN; Maychuk NV; Parshina VA; Kukleva OY
Vestn Oftalmol; 2019; 135(3):67-77. PubMed ID: 31393449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
